General Information of Drug (ID: DMZ40RQ)

Drug Name
Propyl-(4,5,6,7-tetrahydro-2H-indazol-5-yl)-amine
Synonyms CHEMBL80414; 2H-Indazol-5-amine, 4,5,6,7-tetrahydro-N-propyl-; Propyl-(4,5,6,7-tetrahydro-2H-indazol-5-yl)-amine; SCHEMBL19048481; BDBM50017539
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 179.26
Logarithm of the Partition Coefficient (xlogp) 1.4
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C10H17N3
IUPAC Name
N-propyl-4,5,6,7-tetrahydro-1H-indazol-5-amine
Canonical SMILES
CCCNC1CCC2=C(C1)C=NN2
InChI
InChI=1S/C10H17N3/c1-2-5-11-9-3-4-10-8(6-9)7-12-13-10/h7,9,11H,2-6H2,1H3,(H,12,13)
InChIKey
PYXYUOJSCYNCKM-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
14539719
TTD ID
D05ARI

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Dopamine D2 receptor (D2R) TTEX248 DRD2_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Dopamine D2 receptor (D2R) DTT DRD2 2.50E-02 -0.08 -0.49
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity. J Med Chem. 1989 Oct;32(10):2388-96.